Abstract
To the Editor: In the last years, several groups, including ours, have described the main traits and clinical implications of a stroke-induced immunodepression syndrome.1,2 This syndrome has raised the attention of the scientific community because it opens a field to assay newer diagnostic and therapeutic avenues for stroke. In a recent article in Stroke ,3 Hug et al confirm many of the descriptions made in previous works and conclude that the main determinant of the immune changes that follow stroke and of the risk of stroke-associated infection is infarct volume. Indeed, this conclusion is reassuring because we have repeatedly described that stroke-associated infection is a marker of the severity of the disease.4,5 We have shown that some …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
